Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Next Generation Teledermatology: Meshing Telemedicine Video + AI Technology for Faster and More Accurate Access to Dermatology Care
  • USA - English


News provided by

VSee

Aug 20, 2018, 12:20 ET

Share this article

Share toX

Share this article

Share toX


SAN FRANCISCO (PRWEB) August 20, 2018 -- VSee telemedicine and First Derm Artificial Intelligence (AI)-trained dermatology API are seeking to bridge the gap in dermatology care with teledermatology video visits and AI technology.

Dr. Milton Chen, VSee CEO says "VSee is pleased to be working with First Derm in taking teledermatology to the next level by integrating the best of both video telemedicine and AI dermatology. dermatology. We believe these tools will make a true impact in delivering more efficient and more effective dermatology care."

We have created a dermatology AI on all skin diseases — not only skin cancer

Post this

Dr. Alexander Börve founder of First Derm says "We have created a dermatology AI on all skin diseases, not only skin cancer. Working with a telemedicine provider like VSee we can further support primary care providers and extend dermatology services to those who would otherwise not have access."

The US is currently experiencing a dermatologist shortage with an average wait time of 35 days and 40% of patients living in areas underserved by dermatologists. Primary care providers (PCPs) partially offset this shortage. Approximately 15 to 20% of primary care visits are for dermatological related problems including skin cancer, fungal growth, sexually transmitted diseases, acne, hair loss, etc. Yet, most primary care physicians (PCPs) lack confidence in diagnosing these diseases.

The lack of dermatologists in developing countries is even more pronounced. South Africa has a ratio of 3 to 4 million people per dermatologist. And with the exception of the former and Egypt, all other African countries have few dermatology training programs. Thus there is an even greater need globally to access dermatologists and dermatology expertise.

One solution to the dermatology shortage has been the use of teledermatology, which has received favorable responses from both PCPs and dermatologists; however, accuracy continues to be some cause of concern.

Historically, teledermatology is mostly done using store-and-forward technology. Store-and-forward telemedicine allows PCPs to email or upload a picture of the condition along with patient details to the dermatologist. The dermatologist can efficiently give a diagnosis when available without the additional overhead of scheduling a meeting time. While this has helped with access issues, some teledermatology studies question whether store-and-forward teledermatology is as accurate as in-person visits, especially for conditions such as skin cancer. The development of telemedicine systems like VSee and AI-based telehealth apps like First Derm are seeking to solve these access and accuracy problems.

Video telemedicine provides for live real-time video visits allowing providers and patients to satisfy certain legal requirements as well as to help build rapport by visually seeing the person. However traditional videoconferencing systems have complicated IT infrastructure and are inefficiently designed for medical workflows.

VSee telemedicine is specifically designed for fast, simple video visits for patients and providers. For example, VSee allows use of a clip-on or plug-and-play USB dermatoscope for laptops or mobile devices to livestream the skin area of concern while simultaneously seeing patient's faces without the need to toggle between windows. This allows the provider to examine the patient as though face-to-face. In addition, VSee provides a complete virtual clinic with build-your-own online waiting room workflows so practices can customize intake forms, online payment, scheduling, visit notes, and tags for tracking patients and coordinating with staff throughout an online visit.    

The First Derm AI provides PCPs with a dermatology diagnostic support tool without having to wait on a dermatologist to respond via email or a store-and-forward system. First Derm’s dermatology AI has been trained on over 100K annotated skin images. For a submitted image, it provides a single diagnosis with 40% accuracy and a diagnoses of the top 5 alternatives with 80% accuracy - nearly instantly. The dermatology AI can be tried here: https://www.firstderm.com/ai-dermatology/

Put these tools together and family doctors providing telehealth can provide faster and more accurate care access to patients. The use of a VSee telemedicine clinic allows patients to walk-in or self-schedule a visit with their preferred provider and upload photos of the skin condition regardless of where they are. Before the visit, the PCP can review the disease alternatives provided by an integrated First Derm AI API to research the possibilities and decide if the patient needs to be referred to a dermatologist, thus providing a faster and more accurate diagnoses.

Together these tools allow family practices, community and rural health clinics, skilled nursing facilities, etc. to provide faster and better care to those in need.

About VSee
VSee is the only approved video telehealth system used by astronauts aboard the International Space Station. VSee’s complete, scalable platform includes simple HIPAA communications and fast clinic workflows. Its modular design allows for seamless integration into a wide range of use cases including ER diversion, on-call specialist consults, tele-ICU, chronic disease management, tele-rehabilitation, and more. VSee provides telehealth education and thought leadership through its Telehealth Secrets video podcast and telehealth conference. It’s 1200+ clients include Walgreens, MDLIVE, Trinity, McKesson, Ascension, Shell, UMich, and DaVita. Learn more at vsee.com

About First Derm®
San Francisco based First Derm® leads the mobile health revolution by empowering users to submit skin ailments anonymously to board-certified dermatologists with photos and a symptom description, from anywhere in the world, in any internet connected device. First Derm® is backed by scientific research as a triage service, yielding an information-based response and suggested course of action. Since the service can be accessed any time in any internet connected device, users receive a reliable review of their ailment directly from a board-certified dermatologist, even on holidays and weekends. First Derm® is available for free download on both iOS and Android, as well via our online widget. For more information, please visit https://www.FirstDerm.com

Anne Chang, VSee, http://vsee.com, +1 6265131824, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.